Literature DB >> 27839915

Primary spinal intradural extramedullary lymphoma: A novel management strategy.

Angelique Sao-Mai Do1, Gabriel A Smith2, Jonathan Pace3, Alia Hdeib4, Manish K Kasliwal5.   

Abstract

Primary spinal intradural extramedullary lymphoma remains a very rare entity in spinal oncology. In this case report, we present the first treatment of a PSIEL diagnosed by cytopathologic analysis alone followed by urgent radio- and chemotherapy in the literature. At 18-month follow-up, our patient was ambulatory with near total imaging resolution of the lesion. In conclusion, surgical excision or biopsy may not be necessary when suspicion for PSIEL exists, and may delay prompt medical and radiation treatment due to necessity for wound healing. Further research into the management of extramedullary lymphoma treatment strategies is warranted.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lumbar puncture; Lymphoma; Radiotherapy; Spinal cord compression

Mesh:

Year:  2016        PMID: 27839915     DOI: 10.1016/j.jocn.2016.10.033

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

Review 1.  Molecular profiling of primary central nervous system lymphomas - predictive and prognostic value?

Authors:  K Grace Ho; Christian Grommes
Journal:  Curr Opin Neurol       Date:  2019-12       Impact factor: 5.710

2.  Primary intradural extramedullary spinal Burkitt's lymphoma mimicking a nerve sheath tumor: a case report.

Authors:  Tungish Bansal; Saumya Sahu; Mehar C Sharma; Sachin Borkar
Journal:  Spinal Cord Ser Cases       Date:  2022-05-14

3.  Primary Intradural Extramedullary Spinal Burkitt's Lymphoma: A Case Report.

Authors:  Senai Goitom Sereke; Felix Bongomin; Zeridah Muyinda
Journal:  Int Med Case Rep J       Date:  2020-12-31

4.  Intradural primary marginal zone lymphoma of the cervical spine 2 years following a posterior cervical instrumented fusion.

Authors:  Roee Ber; Stephanie Livingston; Erich G Anderer
Journal:  Int Cancer Conf J       Date:  2021-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.